News | News By Subject | News by Disease News By Date | Search News

Dystonia News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News

News from Around the Web

Press Releases
Portage Biotech's Biohaven Doses First Human Subject In Phase 1 Trial With Lead Drug Candidate BHV-0223     8/27/2015
Portage Biotech's Biohaven's Lead Drug Candidate Clears FDA Investigational New Drug Application (IND) Review And Clinical Studies To Begin     8/24/2015
Ipsen (IPN.PA) Announces Clinical Results Of Dysport® Next Generation (DNG) And Its Intent To File The First Ready-To-Use Liquid Toxin A In Europe And ROW1     2/5/2014
Chronic Treatment With Addex Therapeutics (ADXN.SW) Dipraglurant Rescues Impairment of Long-Term Synaptic Plasticity in a Validated Preclinical Model of Primary Generalized Torsion Dystonia 1     9/4/2013
European Medicines Agency Grants Orphan Designation to Edison Pharmaceuticals, Inc. for EPI-743 for Treatment of Leigh Syndrome     9/12/2012
DMRF-Supported Investigators Close In On Function of Protein Associated with Dystonia     7/20/2011
Mentor Corporation (MNTR) Begins U.S. Phase 1 Study Of Its Botulinum Toxin Product For Spasmodic Torticollis/Cervical Dystonia     5/15/2006
Solstice Neurosciences, Inc. Releases New Data Confirming Effectiveness Of Myobloc As A First-Line Therapy     4/6/2006
Solstice Neurosciences, Inc. Head-To-Head Trial Shows That Myobloc(R)/NeuroBloc(R) Clinically Equivalent To Botox(R) In Cervical Dystonia     6/21/2005

//-->